Lobbying Filing Details

Total Spending

$450,000

Activities

3

Lobbyists

3

Gov't Entities

6

Filing Information
Filing UUID:
17780ebb-228e-4a40-b730-e60dcc381d66
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 11:39 PM
Income:
$0
Expenses:
$450,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Deirdre Parsons
Registrant
ALNYLAM PHARMACEUTICALS, INC.
Cambridge, Massachusetts
Client
ALNYLAM PHARMACEUTICALS, INC.

Pharmaceutical manufacturer

Massachusetts, United States of America
Lobbying Activities (3)
Activity 1
Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing

Lobbyists (3)
  • MS. DEIRDRE BRADFORD PARSONS
  • CURTIS RHYNE
  • MARGARET HERMAN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Pharmacy

Implementation of The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (PL 116-94); issues related to drug pricing; FY2026 Labor HHS appropriations, issues related to genetically targeted technologies; HR1672, Maintaining Investments in New Innovation Act.

Lobbyists (3)
  • MS. DEIRDRE BRADFORD PARSONS
  • CURTIS RHYNE
  • MARGARET HERMAN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Trade (domestic/foreign)

Issues relating to supply chain tariffs

Lobbyists (3)
  • MS. DEIRDRE BRADFORD PARSONS
  • CURTIS RHYNE
  • MARGARET HERMAN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 18, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.